article thumbnail

Zocdoc CEO Predicts 5 Ways Patient Behavior Will Change in 2024

MedCity News

Zocdoc Founder and CEO Oliver Kharraz gave five predictions about how patient preferences will evolve in 2024. Some of them include Americans increasingly seeking cash-pay care options and an uptick in patients seeking mental health appointments before and after the presidential election.

Patients 114
article thumbnail

Telehealth, Patient Reviews, and Retailization – 2024 Healthcare Digital Marketing Trends

MedCity News

Here are 5 healthcare marketing trends to pay attention to in 2024. To meet evolving consumer expectations, providers must have a strong digital marketing strategy and user experience online.

Retail 117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patient Privacy in 2024

Penrod

Additionally, OCR specifies that when a healthcare entity subject to HIPAA collects such information, like when a potential patient seeks services in their area, that data is classified as Protected Health Information (PHI). In addition to these states, several more have privacy laws set to go into effect in 2024.

article thumbnail

Will We Close the Medicare Advantage Primary Care Gap in 2024?

MedCity News

Medicare Advantage patients without a primary care physician are perhaps the greatest risk to health plans in 2024. Health plans must adopt best practices to reach and engage MA patients, especially those with multiple, complex conditions. Here are six best practices to consider.

article thumbnail

CHMP meeting highlights: February 2024

European Pharmaceutical Review

At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. Clinical data showed approximately 60 percent reductions in plasma NfL concentrations in patients given Qalsody compared to placebo.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. More recent developments provide a look into Amazon’s interest in treating patients with chronic conditions, including a pharmacy consultation pilot for high-risk seniors with complex medical needs.

Retail 52
article thumbnail

CHMP meeting highlights: January 2024

European Pharmaceutical Review

The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. CHMP’s September 2023 meeting highlights The post CHMP meeting highlights: January 2024 appeared first on European Pharmaceutical Review.